Decoy Therapeutics Inc.
DCOYNasdaqCIK 1615219HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | 0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | not reported | not reported | not reported | 228Revenue, Q2 FY2026, three months to 2026-06-30$227.6k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure |
| Cost of revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $k | 1,036Research and development, Q3 FY2023, three months to 2023-09-30$1.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001615219-24-000089.Report this figure | 60.0Research and development, Q4 FY2023, three months to 2023-12-31$60.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-21, accession 0001615219-25-000037. Derived: 12-month figure less the 9-month figure.Report this figure | 243Research and development, Q1 FY2024, three months to 2024-03-31$243.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001615219-25-000048.Report this figure | 214Research and development, Q2 FY2024, three months to 2024-06-30$214.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001615219-25-000096.Report this figure | 137Research and development, Q3 FY2024, three months to 2024-09-30$137.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | 175Research and development, Q4 FY2024, three months to 2024-12-31$175.3k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-134897. Derived: 12-month figure less the 9-month figure.Report this figure | 75.5Research and development, Q1 FY2025, three months to 2025-03-31$75.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | 116Research and development, Q2 FY2025, three months to 2025-06-30$116.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | 61.8Research and development, Q3 FY2025, three months to 2025-09-30$61.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | 114Research and development, Q4 FY2025, three months to 2025-12-31$114.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-134897. Derived: 12-month figure less the 9-month figure.Report this figure | 750Research and development, Q1 FY2026, three months to 2026-03-31$749.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | 1,304Research and development, Q2 FY2026, three months to 2026-06-30$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure |
| Operating income | $k | (2,532)Operating income, Q3 FY2023, three months to 2023-09-30−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001615219-24-000089.Report this figure | (971)Operating income, Q4 FY2023, three months to 2023-12-31−$970.7k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-21, accession 0001615219-25-000037. Derived: 12-month figure less the 9-month figure.Report this figure | (1,772)Operating income, Q1 FY2024, three months to 2024-03-31−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001615219-25-000048.Report this figure | (1,468)Operating income, Q2 FY2024, three months to 2024-06-30−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001615219-25-000096.Report this figure | (1,006)Operating income, Q3 FY2024, three months to 2024-09-30−$1.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | (1,489)Operating income, Q4 FY2024, three months to 2024-12-31−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134897. Derived: 12-month figure less the 9-month figure.Report this figure | (1,719)Operating income, Q1 FY2025, three months to 2025-03-31−$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | (966)Operating income, Q2 FY2025, three months to 2025-06-30−$965.6k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | (895)Operating income, Q3 FY2025, three months to 2025-09-30−$895.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | (9,035)Operating income, Q4 FY2025, three months to 2025-12-31−$9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134897. Derived: 12-month figure less the 9-month figure.Report this figure | (2,284)Operating income, Q1 FY2026, three months to 2026-03-31−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | (2,631)Operating income, Q2 FY2026, three months to 2026-06-30−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | (2,443)Net income, Q3 FY2023, three months to 2023-09-30−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001615219-24-000089.Report this figure | (882)Net income, Q4 FY2023, three months to 2023-12-31−$881.8k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-21, accession 0001615219-25-000037. Derived: 12-month figure less the 9-month figure.Report this figure | (1,715)Net income, Q1 FY2024, three months to 2024-03-31−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | (1,424)Net income, Q2 FY2024, three months to 2024-06-30−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | (972)Net income, Q3 FY2024, three months to 2024-09-30−$972.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | (1,464)Net income, Q4 FY2024, three months to 2024-12-31−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134897. Derived: 12-month figure less the 9-month figure.Report this figure | (1,710)Net income, Q1 FY2025, three months to 2025-03-31−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | (958)Net income, Q2 FY2025, three months to 2025-06-30−$957.8k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | (873)Net income, Q3 FY2025, three months to 2025-09-30−$873.5k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | (8,978)Net income, Q4 FY2025, three months to 2025-12-31−$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134897. Derived: 12-month figure less the 9-month figure.Report this figure | (2,225)Net income, Q1 FY2026, three months to 2026-03-31−$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | (2,374)Net income, Q2 FY2026, three months to 2026-06-30−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure |
| Diluted EPS | $ per share | (5.21)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$5.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001615219-24-000089.Report this figure | not reported | (3.27)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$3.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001615219-25-000048.Report this figure | (2.37)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$2.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001615219-25-000096.Report this figure | (11.38)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$11.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | not reported | (240.07)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$240.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | (81.21)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$81.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | (1.81)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | not reported | (4.18)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$4.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | (4.46)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$4.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure |
| Basic EPS | $ per share | (5.21)Basic EPS, Q3 FY2023, three months to 2023-09-30−$5.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001615219-24-000089.Report this figure | not reported | (3.27)Basic EPS, Q1 FY2024, three months to 2024-03-31−$3.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001615219-25-000048.Report this figure | (2.37)Basic EPS, Q2 FY2024, three months to 2024-06-30−$2.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001615219-25-000096.Report this figure | (11.38)Basic EPS, Q3 FY2024, three months to 2024-09-30−$11.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | not reported | (240.07)Basic EPS, Q1 FY2025, three months to 2025-03-31−$240.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | (81.21)Basic EPS, Q2 FY2025, three months to 2025-06-30−$81.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | (1.81)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.81 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | not reported | (4.18)Basic EPS, Q1 FY2026, three months to 2026-03-31−$4.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | (4.46)Basic EPS, Q2 FY2026, three months to 2026-06-30−$4.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure |
Balance sheet
| Line item | Unit | Q3 FY20232023-09-30 | FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | 7.6Cash and equivalents, Q3 FY2023, at 2023-09-30$7.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001615219-23-000071.Report this figure | 5.9Cash and equivalents, FY2023, at 2023-12-31$5.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-21, accession 0001615219-25-000037.Report this figure | 4.4Cash and equivalents, Q1 FY2024, at 2024-03-31$4.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-13, accession 0001615219-24-000040.Report this figure | 3.3Cash and equivalents, Q2 FY2024, at 2024-06-30$3.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-09, accession 0001615219-24-000071.Report this figure | 3.3Cash and equivalents, Q3 FY2024, at 2024-09-30$3.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001615219-24-000089.Report this figure | 2.4Cash and equivalents, FY2024, at 2024-12-31$2.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001193125-26-134897.Report this figure | 1.8Cash and equivalents, Q1 FY2025, at 2025-03-31$1.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001615219-25-000048.Report this figure | 0.8Cash and equivalents, Q2 FY2025, at 2025-06-30$794.9k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001615219-25-000096.Report this figure | 4.8Cash and equivalents, Q3 FY2025, at 2025-09-30$4.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | 10.7Cash and equivalents, FY2025, at 2025-12-31$10.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | 7.8Cash and equivalents, Q1 FY2026, at 2026-03-31$7.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | 8.3Cash and equivalents, Q2 FY2026, at 2026-06-30$8.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure |
| Current assets | $m | 8.3Current assets, Q3 FY2023, at 2023-09-30$8.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001615219-23-000071.Report this figure | 6.5Current assets, FY2023, at 2023-12-31$6.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-21, accession 0001615219-25-000037.Report this figure | 4.8Current assets, Q1 FY2024, at 2024-03-31$4.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0001615219-24-000040.Report this figure | 3.5Current assets, Q2 FY2024, at 2024-06-30$3.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0001615219-24-000071.Report this figure | 3.8Current assets, Q3 FY2024, at 2024-09-30$3.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001615219-24-000089.Report this figure | 3.0Current assets, FY2024, at 2024-12-31$3.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001193125-26-134897.Report this figure | 2.3Current assets, Q1 FY2025, at 2025-03-31$2.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001615219-25-000048.Report this figure | 1.4Current assets, Q2 FY2025, at 2025-06-30$1.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001615219-25-000096.Report this figure | 6.1Current assets, Q3 FY2025, at 2025-09-30$6.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | 11.0Current assets, FY2025, at 2025-12-31$11.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | 8.4Current assets, Q1 FY2026, at 2026-03-31$8.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | 8.6Current assets, Q2 FY2026, at 2026-06-30$8.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure |
| Total assets | $m | 8.4Total assets, Q3 FY2023, at 2023-09-30$8.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001615219-23-000071.Report this figure | 6.6Total assets, FY2023, at 2023-12-31$6.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-21, accession 0001615219-25-000037.Report this figure | 4.9Total assets, Q1 FY2024, at 2024-03-31$4.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0001615219-24-000040.Report this figure | 3.6Total assets, Q2 FY2024, at 2024-06-30$3.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0001615219-24-000071.Report this figure | 3.9Total assets, Q3 FY2024, at 2024-09-30$3.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001615219-24-000089.Report this figure | 3.0Total assets, FY2024, at 2024-12-31$3.0m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001193125-26-134897.Report this figure | 2.3Total assets, Q1 FY2025, at 2025-03-31$2.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001615219-25-000048.Report this figure | 1.4Total assets, Q2 FY2025, at 2025-06-30$1.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001615219-25-000096.Report this figure | 6.1Total assets, Q3 FY2025, at 2025-09-30$6.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | 11.1Total assets, FY2025, at 2025-12-31$11.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | 8.4Total assets, Q1 FY2026, at 2026-03-31$8.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | 9.0Total assets, Q2 FY2026, at 2026-06-30$9.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | 1.5Current liabilities, FY2024, at 2024-12-31$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001193125-26-134897.Report this figure | not reported | not reported | not reported | 5.2Current liabilities, FY2025, at 2025-12-31$5.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | 4.5Current liabilities, Q1 FY2026, at 2026-03-31$4.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | 4.7Current liabilities, Q2 FY2026, at 2026-06-30$4.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure |
| Total liabilities | $m | 2.3Total liabilities, Q3 FY2023, at 2023-09-30$2.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001615219-23-000071.Report this figure | 1.3Total liabilities, FY2023, at 2023-12-31$1.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-21, accession 0001615219-25-000037.Report this figure | 1.2Total liabilities, Q1 FY2024, at 2024-03-31$1.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0001615219-24-000040.Report this figure | 1.2Total liabilities, Q2 FY2024, at 2024-06-30$1.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0001615219-24-000071.Report this figure | 0.9Total liabilities, Q3 FY2024, at 2024-09-30$934.6k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001615219-24-000089.Report this figure | 1.5Total liabilities, FY2024, at 2024-12-31$1.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001193125-26-134897.Report this figure | 2.3Total liabilities, Q1 FY2025, at 2025-03-31$2.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001615219-25-000048.Report this figure | 2.2Total liabilities, Q2 FY2025, at 2025-06-30$2.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001615219-25-000096.Report this figure | 1.8Total liabilities, Q3 FY2025, at 2025-09-30$1.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | 5.2Total liabilities, FY2025, at 2025-12-31$5.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | 4.5Total liabilities, Q1 FY2026, at 2026-03-31$4.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | 4.7Total liabilities, Q2 FY2026, at 2026-06-30$4.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure |
| Shareholders' equity | $m | 6.1Shareholders' equity, Q3 FY2023, at 2023-09-30$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001615219-24-000089.Report this figure | 5.3Shareholders' equity, FY2023, at 2023-12-31$5.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001193125-26-134897.Report this figure | 3.6Shareholders' equity, Q1 FY2024, at 2024-03-31$3.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | 2.4Shareholders' equity, Q2 FY2024, at 2024-06-30$2.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | 2.9Shareholders' equity, Q3 FY2024, at 2024-09-30$2.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | 1.5Shareholders' equity, FY2024, at 2024-12-31$1.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | 0.1Shareholders' equity, Q1 FY2025, at 2025-03-31$61.9k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | (0.8)Shareholders' equity, Q2 FY2025, at 2025-06-30−$829.7k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | 4.2Shareholders' equity, Q3 FY2025, at 2025-09-30$4.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001615219-25-000164.Report this figure | 5.9Shareholders' equity, FY2025, at 2025-12-31$5.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | 3.9Shareholders' equity, Q1 FY2026, at 2026-03-31$3.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure | 4.3Shareholders' equity, Q2 FY2026, at 2026-06-30$4.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346852.Report this figure |
Cash flow
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $k | (3,749)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$3.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001615219-24-000089. Derived: 9-month figure less the 6-month figure.Report this figure | (1,511)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-21, accession 0001615219-25-000037. Derived: 12-month figure less the 9-month figure.Report this figure | (1,354)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001615219-25-000048.Report this figure | (1,072)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001615219-25-000096. Derived: 6-month figure less the 3-month figure.Report this figure | (1,357)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001615219-25-000164. Derived: 9-month figure less the 6-month figure.Report this figure | (743)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$742.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-134897. Derived: 12-month figure less the 9-month figure.Report this figure | (1,182)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | (862)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$862.3k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-346852. Derived: 6-month figure less the 3-month figure.Report this figure | (1,647)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001615219-25-000164. Derived: 9-month figure less the 6-month figure.Report this figure | (1,136)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-134897. Derived: 12-month figure less the 9-month figure.Report this figure | (2,889)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-214816.Report this figure | (2,652)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-346852. Derived: 6-month figure less the 3-month figure.Report this figure |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
Shares
| Line item | Unit | Q3 FY20222022-09-30 | Q1 FY20232023-03-31 | Q2 FY20232023-06-30 | Q3 FY20232023-09-30 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | k shares | 2,248 | 2,392 | 339 | 469 | 524 | 600 | 85.5 | 7.1 | 11.8 | 482 | 532 | 532 |
Shares outstanding: 655,185 at Aug 12, 2026, from the cover of the 10-Q filed Aug 12, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.